Cargando…

Insights from pharmacogenetic studies of antidepressants

Detalles Bibliográficos
Autor principal:	Mandelli, Laura
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991995/ http://dx.doi.org/10.1186/1744-859X-9-S1-S8

Ejemplares similares

Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009)

Pharmacogenetics of Antidepressants
por: Crisafulli, Concetta, et al.
Publicado: (2011)

Pharmacogenetics and antidepressant treatment outcomes in pregnancy: a Danish-population based study
por: Mushtaq, M., et al.
Publicado: (2022)

Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2015)

Pharmacogenetics of antidepressant response: An update
por: Drago, Antonio, et al.
Publicado: (2009)

Novel approaches such as pharmacogenetics and liquid biopsies in tumor treatment in the era of personalized therapy
por: Kralickova, Milena, et al.
Publicado: (2014)

Analyses of Pharmacokinetic, Pharmacogenetic and Psychometrics Correlates of Antidepressants Use during Pregnancy and the Post-Partum Period
por: Cafaro, R., et al.
Publicado: (2022)

Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study)
por: Ter Hark, S., et al.
Publicado: (2023)

A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy
por: Del Re, Marzia, et al.
Publicado: (2014)

Optimization of Antidepressant use with Pharmacogenetic Strategies
por: Torrellas, Clara, et al.
Publicado: (2017)

Remarkably lower consumption of antidepressants in Serbia in comparison with Finland
por: Stojančević, Maja, et al.
Publicado: (2012)

The galanin system in depression and antidepressant treatment: focus on the locus coeruleus
por: Sartori, Simone B, et al.
Publicado: (2012)

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
por: Radosavljevic, Milica, et al.
Publicado: (2023)

Do the binding sites of substrates and tricyclic antidepressants overlap on the serotonin transporter?
por: Sarker, Subhodeep, et al.
Publicado: (2008)

Using a preclinical approach to reveal potential mechanisms of ADRs to antidepressants in adolescents
por: Tsapakis, Evangelia M
Publicado: (2010)

Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011)

The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter
por: Sarker, Subhodeep, et al.
Publicado: (2010)

Antidepressant-like effects of benzodiazepine site inverse agonists in the rat forced swim test
por: Samardžić, Janko, et al.
Publicado: (2012)

Prescriptions of antidepressants and anxiolytics in survivors of out-of-hospital cardiac arrest - a nationwide register-based follow-up study
por: Bundgaard, Kristian, et al.
Publicado: (2015)

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action
por: Ochi, Taichi, et al.
Publicado: (2021)

Adult neurogenesis in a psychopathological mouse model of trait anxiety and comorbid depression-like behavior: effect of antidepressants
por: Sah, Anupam, et al.
Publicado: (2009)

Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice
por: Maitland-van der Zee, Anke-Hilse, et al.
Publicado: (2010)

SLE: insights from array-based proteomics
por: Wu, T, et al.
Publicado: (2012)

EXPERIENCE OF PHARMACOGENETIC TESTING IN THE TREATMENT OF ANTIPSYCHOTICS
por: Kaydan, M., et al.
Publicado: (2023)

An update of clinical issues from InSIGHT 2011
por: Lipton, L
Publicado: (2012)

Chromosomal instability and cancer predisposition: insights from studies on the breast cancer susceptibility gene BRCA2
por: Venkitaraman, A
Publicado: (2001)

In Silico Pharmacogenetics CYP2D6 Study Focused on the Pharmacovigilance of Herbal Antidepressants
por: Don, Charleen G., et al.
Publicado: (2020)

Coded data quality for Casemix payment: insights from two external audits
por: Reid, B, et al.
Publicado: (2011)

Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools
por: Bousman, Chad A., et al.
Publicado: (2017)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

A new insight into FEIA
por: Yan Fei Chen, Jennifer, et al.
Publicado: (2011)

New insights into HTLV entry
por: Pique, Claudine, et al.
Publicado: (2011)

Viral DNA replication: new insights and discoveries from large scale computational analysis
por: Kazlauskas, Darius, et al.
Publicado: (2015)

S222. CLINICAL UTILITY OF PHARMACOGENETIC TESTING IN SCHIZOPHRENIA TREATMENT
por: Mueller, Daniel, et al.
Publicado: (2018)

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
por: Tuteja, Sony, et al.
Publicado: (2021)

Glutamine synthetase mutations that cause glutamine deficiency: mechanistic insights from molecular dynamics simulations
por: Frieg, Benedikt, et al.
Publicado: (2014)

EHMTI-0332. Health care utilisation for primary headache disorders: insights from Karnataka, India
por: Rao, G, et al.
Publicado: (2014)

Molecular dissection of human B-cell tolerance – insights from patients with rare genetic diseases
por: Morbach, Henner, et al.
Publicado: (2014)

Genetic insights into breast cancer risk
por: Wong-Brown, Michelle, et al.
Publicado: (2015)

New insights in vitiligo: cellular immune response
por: Ferraroni, Natasha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mesdfl3qr7s7j7ftnah36p89tq